Bridgefront Capital, LLC Repligen Corp Transaction History

Bridgefront Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$140.68 - $188.02 $316,952 - $423,609	2,253 New	2,253 $366,000
Q1 2022 May 13, 2022	SELL	$161.19 - $257.96 $132,498 - $212,043	-822 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$247.59 - $304.47 $203,518 - $250,274	822 New	822 $218,000
Q2 2021 Aug 12, 2021	SELL	$165.87 - $220.95 $198,048 - $263,814	-1,194 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$180.37 - $226.26 $215,361 - $270,154	1,194 New	1,194 $232,000

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgefront Capital, LLC with notifications on news.